2024 | 2023 | ||||||
Pre- | Exceptional | Pre- | Exceptional | ||||
exceptional | $m | Total | exceptional | $m | Total | ||
Notes | $m | (note 6) | $m | $m | (note 6) | $m | |
Continuing operations | |||||||
Revenue* | 4 | ||||||
Cost of goods sold* | ( | ( | ( | ( | |||
Gross profit | |||||||
Selling and distribution expenses | ( | ( | ( | ( | ( | ||
Administration expenses | ( | ( | ( | ( | ( | ||
Net impairment gain on financial assets | 5 | ||||||
Operating profit before intangible asset amortisation | |||||||
and impairment | ( | ||||||
Intangible asset amortisation and impairment | 16 | ( | ( | ( | ( | ( | |
Operating profit | ( | ||||||
Finance income | 10 | ||||||
Finance costs | 10 | ( | ( | ( | ( | ||
Share of results of joint ventures accounted for using the equity method | 17 | ||||||
Profit before taxation | ( | ||||||
Income taxes | 11 | ( | ( | ( | ( | ||
Profit from continuing operations | ( | ||||||
Discontinued operations | |||||||
Loss after tax from discontinued operations | 33 | ( | ( | ||||
Profit for the year | ( | ||||||
Attributable to: | |||||||
Equity holders of the Company | 24 | ||||||
Non-controlling interests | |||||||
Earnings Per Share from continuing operations attributable to the equity holders of the Company | |||||||
Basic Earnings Per Share (cent) | 12 | ||||||
Diluted Earnings Per Share (cent) | 12 | ||||||
Earnings Per Share attributable to the equity holders of the Company | |||||||
Basic Earnings Per Share (cent) | 12 | ||||||
Diluted Earnings Per Share (cent) | 12 |
2024 | 2023 | ||
Notes | $m | $m | |
Profit for the year | |||
Other comprehensive income | |||
Items that will not be reclassified subsequently to the Group income statement: | |||
Remeasurements on defined benefit plans, net of deferred tax | |||
Revaluation of equity investments at FVOCI, net of deferred tax | 23 | ||
Share of other comprehensive income of joint ventures accounted for using the equity | |||
method, net of deferred tax | 17 | ||
Items that may be reclassified subsequently to the Group income statement: | |||
Currency translation differences | 23 | ( | |
Currency translation difference arising on net investment hedge | 23 | ( | |
Movement in cash flow hedges, net of deferred tax | 23(c) | ( | |
Share of other comprehensive income of joint ventures accounted for using the equity | |||
method, net of deferred tax | 17 | ( | ( |
Other comprehensive income for the year, net of tax | ( | ||
Total comprehensive income for the year | |||
Attributable to: | |||
Equity holders of the Company | |||
Non-controlling interests | |||
Total comprehensive income for the year |
4 January | 30 December | ||
2025 | 2023 | ||
Notes | $m | $m | |
ASSETS | |||
Non-current assets | |||
Property, plant and equipment | 14 | ||
Right-of-use assets | 15 | ||
Intangible assets | 16 | ||
Interests in joint ventures | 17 | ||
Other financial assets | 18 | ||
Deferred tax assets | 26 | ||
Retirement benefit assets | 8 | ||
Current assets | |||
Inventories | 20 | ||
Trade and other receivables | 19 | ||
Current tax receivable | |||
Derivative financial instruments | 29(a) | ||
Cash and cash equivalents (excluding bank overdrafts) | 21 | ||
Assets held for sale | 33 | ||
Total assets | |||
EQUITY | |||
Issued capital and reserves attributable to equity holders of the Company | |||
Share capital and share premium | 22 | ||
Other reserves | 23 | ||
Retained earnings | 24 | ||
Total equity | |||
LIABILITIES | |||
Non-current liabilities | |||
Borrowings | 25 | ||
Lease liabilities | 15 | ||
Retirement benefit obligations | 8 | ||
Deferred tax liabilities | 26 | ||
Provisions | 27 | ||
Current liabilities | |||
Trade and other payables | 28 | ||
Borrowings | 25 | ||
Lease liabilities | 15 | ||
Current tax liabilities | |||
Derivative financial instruments | 29(a) | ||
Provisions | 27 | ||
Liabilities held for sale | 33 | ||
Total liabilities | |||
Total equity and liabilities |
Attributable to equity holders of the Company | ||||||
Share capital | Non- | |||||
and share | Other | Retained | controlling | |||
premium | reserves | earnings | Total | interests | Total | |
$m | $m | $m | $m | $m | $m | |
2024 | (note 22) | (note 23) | (note 24) | |||
Balance at 31 December 2023 | ||||||
Profit for the year | ||||||
Other comprehensive income | ( | ( | ( | |||
Total comprehensive income for the year | ( | |||||
Dividends | ( | ( | ( | |||
Purchase of own shares | ( | ( | ( | |||
Cancellation of own shares | ( | ( | ||||
Share-based payment expense | ||||||
Transfer on exercise, vesting or expiry of share-based | ||||||
payments | ( | |||||
Deferred tax on share-based payments | ( | ( | ( | |||
Balance at 4 January 2025 | ||||||
2023 | ||||||
Balance at 1 January 2023 | ||||||
Profit for the year | ||||||
Other comprehensive income | ||||||
Total comprehensive income for the year | ||||||
Dividends | ( | ( | ( | |||
Purchase of own shares | ( | ( | ( | |||
Cancellation of own shares | ( | ( | ||||
Share-based payment expense | ||||||
Transfer on exercise, vesting or expiry of share-based | ||||||
payments | ( | |||||
Deferred tax on share-based payments | ||||||
Acquisition of NCI | ( | ( | ||||
Transfer to Group income statement | ||||||
Balance at 30 December 2023 |
2024 | 2023 | ||
Notes | $m | $m | |
Cash flows from operating activities | |||
Cash generated from operating activities before exceptional items | 32(a) | ||
Cash outflow related to exceptional items | ( | ( | |
Interest received | |||
Interest paid (including interest paid on lease liabilities) | ( | ( | |
Tax paid | ( | ( | |
Net cash inflow from operating activities | |||
Cash flows from investing activities | |||
Payment for acquisition of subsidiary, net of cash acquired | ( | ( | |
Purchase of property, plant and equipment | ( | ( | |
Purchase of intangible assets | 16 | ( | ( |
Proceeds from sale of property, plant and equipment | |||
Dividends received from related parties | |||
Proceeds from disposal/redemption of FVOCI financial assets | |||
Proceeds from disposal of Leprino Foods (exceptional) | |||
Proceeds on repayment of loans advanced to Leprino Foods EU Limited | 35 | ||
Loans advanced to Leprino Foods EU Limited | 35 | ( | |
Proceeds from disposal of assets and liabilities held for sale (exceptional) | |||
Net cash outflow from discontinued operations | ( | ||
Net cash (outflow)/inflow from investing activities | ( | ||
Cash flows from financing activities | |||
Purchase of own shares | 23 | ( | ( |
Drawdown of borrowings | 25/32(c) | ||
Repayment of borrowings | 25/32(c) | ( | ( |
Payment of lease liabilities | 32(c) | ( | ( |
Payment for acquisition of NCI | ( | ||
Dividends paid to Company shareholders | 13/24 | ( | ( |
Net cash outflow from financing activities | ( | ( | |
Net (decrease)/increase in cash and cash equivalents | 25 | ( | |
Cash and cash equivalents at the beginning of the year | |||
Effects of exchange rate changes on cash and cash equivalents | ( | ||
Cash and cash equivalents at the end of the year | 21 |
Average | Closing Rates | |||
1 US dollar = | 2024 | 2023 | 2024 | 2023 |
euro | 0.9246 | 0.9247 | 0.9710 | 0.9050 |
Pound sterling | 0.7827 | 0.8043 | 0.8058 | 0.7865 |
% | |
Land | Nil |
Buildings | 2.5-5 |
Plant and equipment | 4-33 |
Motor vehicles | 20-25 |
Years | |
Brands | 3–40 |
Customer relationships | 5–15 |
Recipes, know-how and other intangibles | 2–15 |
2024 | 2023 | |||||||
All other | All other | |||||||
Glanbia | segments | Glanbia | segments | |||||
Performance | Glanbia | and | Performance | Glanbia | and | |||
Nutrition | Nutritionals* | unallocated | Total | Nutrition | Nutritionals | unallocated | Total | |
$m | $m | $m | $m | $m | $m | $m | $m | |
Segment results (pre-exceptional) | ||||||||
Total gross segment revenue | 1,807.3 | 2,098.5 | – | 3,905.8 | 1,795.7 | 3,7 17.4 | – | 5,513.1 |
Inter-segment revenue | (0.6) | (65.5) | – | (66.1) | (0.1) | (87.6) | – | (87.7) |
Revenue | 1,806.7 | 2,033.0 | – | 3,839.7 | 1,795.6 | 3,629.8 | – | 5,425.4 |
Earnings before interest, tax, depreciation, amortisation and exceptional items (EBITDA)** | 305.4 | 245.9 | – | 551.3 | 282.3 | 211.1 | – | 493.4 |
Share of results of joint ventures | ||||||||
accounted for using the equity | ||||||||
method | – | – | 0.1 | 0.1 | – | – | 12.5 | 12.5 |
Segment assets and liabilities | ||||||||
Segment assets | 1,700.9 | 1,525.1 | 648.5 | 3,874.5 | 1,859.6 | 1,285.1 | 654.4 | 3,799.1 |
Segment liabilities | 378.8 | 355.5 | 1,067.4 | 1,801.7 | 394.7 | 403.5 | 868.3 | 1,666.5 |
Other segment information | ||||||||
Depreciation of PP&E | ||||||||
and ROU assets*** | 25.6 | 47.5 | – | 73.1 | 26.9 | 42.5 | – | 69.4 |
Amortisation of intangible assets | 50.8 | 31.3 | – | 82.1 | 56.8 | 22.8 | – | 79.6 |
Exceptional charge/(gain) | 139.8 | 1.1 | 20.5 | 161.4 | 3.4 | 2.2 | (53.4) | (47.8) |
Capital expenditure – additions | 24.4 | 75.5 | 6.4 | 106.3 | 16.1 | 48.9 | 12.6 | 77.6 |
Capital expenditure – business | ||||||||
combinations | – | 285.3 | – | 285.3 | – | 41.8 | – | 41.8 |
2024 | 2023 | ||
Notes | $m | $m | |
Earnings before interest,tax,depreciation,amortisation and exceptional items (EBITDA) | 551.3 | 493.4 | |
Finance income | 10 | 5.4 | 9.8 |
Finance costs | 10 | (32.2) | (22.1) |
Share of results of joint ventures accounted for using the equity method | 0.1 | 12.5 | |
Exceptional items | 6 | (161.4) | 47.8 |
Intangible asset amortisation | 16 | (82.1) | (79.6) |
Depreciation of property, plant and equipment | 14 | (52.2) | (49.7) |
Reversal of impairment of property, plant and equipment | 14 | 1.0 | - |
Depreciation of right-of-use assets | 15 | (21.9) | (19.7) |
Profit before taxation | 208.0 | 392.4 | |
Income taxes | 11 | (43.3) | (44.7) |
Loss after tax from discontinued operations | – | (3.2) | |
Profit for the year | 164.7 | 344.5 |
2024 | 2023 | |||
Non-current | Non-current | |||
Revenue | assets | Revenue | assets | |
$m | $m | $m | $m | |
Ireland (country of domicile) | 45.7 | 1,064.4 | 18.0 | 821.4 |
US* | 2,718.1 | 1,180.8 | 4,296.7 | 1,281.5 |
Other – North America (excluding US) | 115.0 | 5.6 | 106.6 | 6.3 |
– Europe (excluding Ireland) | 471.3 | 108.9 | 473.0 | 178.7 |
– Asia Pacific | 367.9 | 11.3 | 379.3 | 12.0 |
– LATAM | 56.7 | 0.1 | 95.0 | 0.1 |
– Rest of World | 65.0 | – | 56.8 | – |
3,839.7 | 2,371.1 | 5,425.4 | 2,300.0 |
2024 | 2023 | |||||
Glanbia | Glanbia | |||||
Performance | Glanbia | Performance | Glanbia | |||
Nutrition | Nutritionals* | Total | Nutrition | Nutritionals | Total | |
$m | $m | $m | $m | $m | $m | |
Internal reporting structures | ||||||
Nutritional Solutions | – | 1,007.7 | 1,007.7 | – | 1,008.5 | 1,008.5 |
US Cheese | – | 1,025.3 | 1,025.3 | – | 2,621.3 | 2,621.3 |
GPN Americas | 1,161.0 | – | 1,161.0 | 1,166.7 | – | 1,166.7 |
GPN International | 645.7 | – | 645.7 | 628.9 | – | 628.9 |
1,806.7 | 2,033.0 | 3,839.7 | 1,795.6 | 3,629.8 | 5,425.4 | |
Primary geographical markets | ||||||
North America | 1,162.6 | 1,670.5 | 2,833.1 | 1,185.5 | 3,217.8 | 4,403.3 |
Europe | 351.8 | 165.2 | 517.0 | 361.1 | 129.9 | 491.0 |
Asia Pacific | 226.7 | 141.2 | 367.9 | 196.6 | 182.7 | 379.3 |
LATAM | 21.7 | 35.0 | 56.7 | 13.6 | 81.4 | 95.0 |
Rest of World | 43.9 | 21.1 | 65.0 | 38.8 | 18.0 | 56.8 |
1,806.7 | 2,033.0 | 3,839.7 | 1,795.6 | 3,629.8 | 5,425.4 | |
Timing of revenue recognition | ||||||
Products transferred at point in time | 1,806.7 | 2,033.0 | 3,839.7 | 1,795.6 | 3,629.8 | 5,425.4 |
Products transferred over time | – | – | – | – | – | – |
1,806.7 | 2,033.0 | 3,839.7 | 1,795.6 | 3,629.8 | 5,425.4 |
2024 | 2023 | |
Channel mix for Glanbia Performance Nutrition | $m | $m |
Distributor | 363.8 | 369.3 |
Food, Drug, Mass, Club (FDMC) | 635.5 | 630.3 |
Online | 599.5 | 576.3 |
Specialty | 207.9 | 219.7 |
1,806.7 | 1,795.6 |
2024 | 2023 | ||||||
Pre- | Pre- | ||||||
exceptional | Exceptional | Total | exceptional | Exceptional | Total | ||
Notes | $m | $m | $m | $m | $m | $m | |
Cost of inventories recognised as an expense | |||||||
in cost of goods sold* | 20 | (2,163.8) | - | (2,163.8) | (3,850.7) | – | (3,850.7) |
Employee benefit expense | 7 | (557.5) | (5.2) | (562.7) | (495.3) | (6.7) | (502.0) |
Depreciation of property, plant and equipment | 14 | (52.2) | - | (52.2) | (49.7) | – | (49.7) |
Impairment of property, plant and equipment | 14 | - | (2.0) | (2.0) | – | – | – |
Profit/(loss) on disposal of property, plant | |||||||
and equipment | 32(a) | 0.3 | - | 0.3 | (1.2) | – | (1.2) |
Reversal of impairment of property, plant | |||||||
and equipment | 14 | 1.0 | - | 1.0 | – | – | – |
Depreciation of right-of-use assets | 15 | (21.9) | - | (21.9) | (19.7) | – | (19.7) |
Impairment of right-of-use assets | 15 | - | (0.9) | (0.9) | – | – | – |
Amortisation of intangible assets | 16 | (82.1) | - | (82.1) | (79.6) | – | (79.6) |
Impairment of intangible assets | 16 | - | (134.5) | (134.5) | – | – | – |
Loss on disposal of intangible assets | 32(a) | (0.5) | - | (0.5) | – | – | – |
Research and development costs | (23.1) | - | (23.1) | (22.1) | – | (22.1) | |
Lease rentals | (3.8) | - | (3.8) | (4.2) | (0.1) | (4.3) | |
Net impairment gain on financial assets | 1.0 | - | 1.0 | 2.6 | – | 2.6 | |
Auditor’s remuneration | (2.6) | - | (2.6) | (2.3) | – | (2.3) | |
Net foreign exchange loss | (2.4) | - | (2.4) | (0.4) | – | (0.4) |
Other statutory auditor | ||||
Statutory auditor | network firms | |||
2024 | 2023 | 2024 | 2023 | |
$m | $m | $m | $m | |
The audit of the Group financial statements | 1.4 | 1.3 | 1.2 | 1.0 |
Other assurance services | – | – | – | – |
Tax advisory services | – | – | – | – |
Other non-audit services | – | – | – | – |
1.4 | 1.3 | 1.2 | 1.0 |
2024 | 2023 | ||
Notes | $m | $m | |
Group-wide transformation programme | (a) | 18.0 | 6.0 |
Acquisition and integration costs | (b) | 5.7 | – |
Pension related costs | (c) | 0.3 | 2.5 |
Net gain on disposal/exit of operations | (d) | – | (56.3) |
Impairment of non-core assets held for sale | (e) | 46.0 | – |
Impairment of intangible assets | (f) | 91.4 | – |
Total | 161.4 | (47.8) | |
Exceptional tax credit | 11 | (15.8) | (1.8) |
Total exceptional charge/(gain) from continuing operations | 145.6 | (49.6) | |
Exceptional charge after tax from discontinued operations | (g) | – | 3.2 |
Total exceptional charge/(gain) after tax for the year | 32(a) | 145.6 | (46.4) |
2024 | 2023 | ||
Notes | $m | $m | |
Wages and salaries | 467.0 | 415.8 | |
Social insurance costs | 41.5 | 32.6 | |
Retirement benefit costs | |||
– Defined contribution plans | 8 | 17.0 | 14.4 |
– Defined benefit plans | 0.6 | 1.5 | |
17.6 | 15.9 | ||
Other compensation costs | |||
– Private health insurance | 31.8 | 28.4 | |
– Share-based payment expense | 9 | 18.2 | 24.5 |
– Company car allowance | 2.8 | 2.4 | |
52.8 | 55.3 | ||
578.9 | 519.6 |
2024 | 2023 | |
Glanbia Performance Nutrition | 2,163 | 2,040 |
Glanbia Nutritionals | 2,952 | 2,814 |
5,115 | 4,854 |
2024 | 2023 | |
$m | $m | |
Non-current assets | ||
Surplus on defined benefit pension plan | 12.0 | 8.2 |
Non-current liabilities | ||
Deficit on defined benefit pension plan | (1.0) | (1.0) |
Net defined benefit pension plans asset | 11.0 | 7.2 |
ROI | UK | Total | |
2024 | $m | $m | $m |
Fair value of plan assets: | |||
At the beginning of the year | 106.8 | 0.4 | 107.2 |
Interest income | 3.2 | – | 3.2 |
Recognised in profit or loss | 3.2 | – | 3.2 |
Remeasurements | |||
Return of plan assets in excess of interest income | 0.7 | – | 0.7 |
Recognised in OCI | 0.7 | – | 0.7 |
Exchange differences | (7.0) | – | (7.0) |
Contributions paid by the employer | 0.6 | – | 0.6 |
Contributions paid by the employee | 0.3 | – | 0.3 |
Benefits paid | (10.3) | (0.2) | (10.5) |
At the end of the year | 94.3 | 0.2 | 94.5 |
Present value of obligations: | |||
At the beginning of the year | (98.8) | (1.2) | (100.0) |
Current service cost | (0.8) | – | (0.8) |
Interest expense | (2.9) | (0.1) | (3.0) |
Recognised in profit or loss | (3.7) | (0.1) | (3.8) |
Remeasurements | |||
Loss from experience adjustments | (0.4) | 0.1 | (0.3) |
Gain from changes in financial assumptions | 4.2 | – | 4.2 |
Recognised in OCI | 3.8 | 0.1 | 3.9 |
Exchange differences | 6.2 | – | 6.2 |
Contributions paid by the employee | (0.3) | – | (0.3) |
Benefits paid | 10.3 | 0.2 | 10.5 |
At the end of the year | (82.5) | (1.0) | (83.5) |
Net asset/(liability) | 11.8 | (0.8) | 11.0 |
2023 | |||
Fair value of plan assets: | |||
At the beginning of the year | 97.5 | 84.5 | 182.0 |
Interest income | 3.6 | 3.3 | 6.9 |
Settlement loss* | – | (77.0) | (77.0) |
Total amount recognised in profit or loss | 3.6 | (73.7) | (70.1) |
Remeasurements | |||
Return of plan assets in excess of interest income | 3.8 | (7.2) | (3.4) |
Recognised in OCI | 3.8 | (7.2) | (3.4) |
Exchange differences | 3.6 | 2.9 | 6.5 |
Contributions paid by the employer | 3.5 | 1.6 | 5.1 |
Contributions paid by the employee | 0.3 | – | 0.3 |
Benefits paid | (5.5) | (7.7) | (13.2) |
At the end of the year | 106.8 | 0.4 | 107.2 |
Present value of obligations: | |||
At the beginning of the year | (94.4) | (85.9) | (180.3) |
Current service cost | (1.0) | – | (1.0) |
Interest expense | (3.4) | (3.3) | (6.7) |
Settlement gain* | – | 76.3 | 76.3 |
Total amount recognised in profit or loss | (4.4) | 73.0 | 68.6 |
Remeasurements | |||
Gain/(loss) from experience adjustments | 2.8 | (0.8) | 2.0 |
Gain from changes in demographic assumptions | – | 1.5 | 1.5 |
(Loss)/gain from changes in financial assumptions | (4.6) | 6.2 | 1.6 |
Recognised in OCI | (1.8) | 6.9 | 5.1 |
Exchange differences | (3.4) | (2.9) | (6.3) |
Contributions paid by the employee | (0.3) | – | (0.3) |
Benefits paid | 5.5 | 7.7 | 13.2 |
At the end of the year | (98.8) | (1.2) | (100.0) |
Net asset/(liability) | 8.0 | (0.8) | 7.2 |
2024 | 2023 | |||||||
Quoted | Unquoted | Total | Quoted | Unquoted | Total | |||
$m | $m | $m | % | $m | $m | $m | % | |
Equities | ||||||||
– Consumer | 1.2 | − | 1.2 | 1 | 3.3 | − | 3.3 | 3 |
– Financials | 1.7 | − | 1.7 | 2 | 2.5 | − | 2.5 | 2 |
– Information technology | 1.9 | − | 1.9 | 2 | 3.9 | − | 3.9 | 4 |
– Other Corporate bonds | 4.9 | − | 4.9 | 5 | 7.8 | − | 7.8 | 7 |
– Investment grade | 4.1 | − | 4.1 | 4 | 8.5 | − | 8.5 | 8 |
– Non investment grade | 0.3 | − | 0.3 | − | 0.6 | − | 0.6 | 1 |
– Cash | − | − | − | − | 0.1 | − | 0.1 | − |
Government bonds and gilts | 28.4 | − | 28.4 | 30 | 16.3 | − | 16.3 | 15 |
Property | − | 1.9 | 1.9 | 2 | − | 2.4 | 2.4 | 2 |
Cash | 0.4 | 2.9 | 3.3 | 3 | 0.2 | 1.7 | 1.9 | 2 |
Investment funds | 3.5 | − | 3.5 | 4 | 9.2 | − | 9.2 | 9 |
Annuities | − | 43.2 | 43.2 | 47 | − | 50.4 | 50.4 | 47 |
Other | 0.1 | − | 0.1 | − | 0.3 | − | 0.3 | − |
46.5 | 48.0 | 94.5 | 100 | 52.7 | 54.5 | 107.2 | 100 |
2024 | 2023 | |||
ROI | UK | ROI | UK | |
Discount rate | 3.45% | 5.60% | 3.20% | 4.70% |
Inflation rate | 1.85% | 2.80%-3.20% | 2.00% | 2.55%-3.10% |
Future salary increases* | 2.85% | 0.00% | 3.00% | 0.00% |
Future pension increases | 0.00% | 2.75%-3.05% | 0.00% | 2.55%-3.00% |
Mortality rates (years) | ||||
– Male – currently aged 65 years old | 22.0 | 20.2 | 22.1 | 20.7 |
– Female – currently aged 65 years old | 24.5 | 22.4 | 24.4 | 22.9 |
– Male – reaching 65 years of age in 20 years’ time | 23.4 | 21.2 | 24.3 | 21.7 |
– Female – reaching 65 years of age in 20 years’ time | 25.9 | 23.6 | 26.4 | 24.1 |
2024 | 2023 | ||||
Increase | Decrease | Increase | Decrease | ||
Assumption | Change in assumption | $m | $m | $m | $m |
ROI | |||||
Discount rate | 0.50% movement | (4.7) | 5.2 | (6.0) | 6.6 |
Inflation rate | 0.50% movement | 1.1 | (1.0) | 1.4 | (1.3) |
Mortality rate | 1 year movement | 2.3 | (2.3) | 2.7 | (2.7) |
Future salary increases* | |||||
Future pension increases** |
2024 | 2023 | |
ROI | ||
Expected contributions to the defined benefit plans for the coming year ($m) | 0.5 | 0.2 |
Weighted average duration of the defined benefit plans (years) | 14 years | 13 years |
2024 | 2023 | ||||
Notes | $m | $m | |||
The | 2018 | Long-term incentive plan (2018 LTIP) | 13.9 | 18.8 | |
The | 2019 | Restricted Share Plan (2019 RSP) | 1.2 | 1.8 | |
The annual incentive deferred into shares scheme (AIDIS) | 3.1 | 3.9 | |||
7/23/32(a) | 18.2 | 24.5 |
2024 | 2023 | |||||||
2018 | LTIP | 2019 | RSP | 2018 | LTIP | 2019 | RSP | |
At the beginning of the year | 4,053,445 | 181,348 | 4,595,659 | 279,990 | ||||
Granted | 1,057,127 | 212,955 | 1,403,396 | 23,397 | ||||
Vested | (1,655,110) | (115,672) | (1,367,455) | (122,039) | ||||
Lapsed | (421,305) | (20,000) | (578,155) | – | ||||
At the end of the year | 3,034,157 | 258,631 | 4,053,445 | 181,348 | ||||
Weighted average fair value of awards granted | €16.96 | €16.15 | €12.69 | €13.93 |
2024 awards | 2023 awards | |||||||
2018 | LTIP | 2019 | RSP | 2018 | LTIP | 2019 | RSP | |
Year of earliest vesting date | 2025 | 2025-2027 | 2024 | 2024-2025 | ||||
Share price at date of award | €17.89 | €14.81-€18.27 | €13.66 | €13.47-€15.14 | ||||
Expected dividend yield | 1.98% | 2.02%-2.39% | 2.77% | 2.13%-2. | 39% |
2024 | 2023 | ||
Notes | $m | $m | |
Finance income | |||
Interest income on cash and deposits | 5.1 | 4.6 | |
Interest income on swaps | 0.3 | 4.0 | |
Interest income on loans to joint ventures | – | 1.0 | |
Remeasurements of contingent consideration | – | 0.2 | |
Total finance income | 5.4 | 9.8 | |
Finance costs | |||
Bank borrowing costs | (16.0) | (6.4) | |
Finance cost of private placement debt | (10.4) | (10.1) | |
Facility fees | (2.8) | (2.9) | |
Interest expense on lease liabilities | 15 | (3.0) | (2.7) |
Total finance costs | (32.2) | (22.1) | |
Net finance costs | (26.8) | (12.3) |
2024 | 2023 | ||
Notes | $m | $m | |
Current tax | |||
Irish current tax charge | 22.1 | 5.3 | |
Adjustments in respect of prior years | 0.1 | (2.3) | |
Irish current tax for the year | 22.2 | 3.0 | |
Foreign current tax charge | 50.5 | 47.0 | |
Adjustments in respect of prior years | 0.2 | (5.8) | |
Foreign current tax for the year | 50.7 | 41.2 | |
Total current tax | 72.9 | 44.2 | |
Deferred tax | |||
Deferred tax – current year | (28.3) | (5.2) | |
Adjustments in respect of prior years | (1.3) | 5.7 | |
Total deferred tax | 26 | (29.6) | 0.5 |
Tax charge | 43.3 | 44.7 |
2024 | 2023 | ||
Notes | $m | $m | |
Current tax credit on exceptional items | (1.0) | (1.8) | |
Deferred tax credit on exceptional items | (14.8) | – | |
Total tax credit on exceptional items for the year | 6 | (15.8) | (1.8) |
2024 | 2023 | |
$m | $m | |
Profit before tax | 208.0 | 392.4 |
Income tax calculated at Irish rate of 12.5% (2023: 12.5%) | 26.0 | 49.1 |
Earnings at non-standard Irish tax rate | 1.1 | 0.9 |
Difference due to overseas tax rates (capital and trading) | 1.4 | (4.8) |
Adjustment to tax charge in respect of previous periods | (1.0) | (2.3) |
Tax on share of results of joint ventures accounted for using the equity method included in profit before tax | – | (1.6) |
Difference due to permanent differences within exceptional items - non-deductible costs/(non-taxable | ||
income) | 10.2 | (7.2) |
Other reconciling items | 5.6 | 10.6 |
Total tax charge | 43.3 | 44.7 |
2024 | 2023 | |||||
Continuing | Discontinued | Continuing | Discontinued | |||
operations | operations | Total | operations | operations | Total | |
Profit after tax attributable to equity holders | ||||||
of the Company ($m) | 164.7 | – | 164.7 | 347.6 | (3.2) | 344.4 |
Basic Earnings Per Share (cent) | 63.21 | – | 63.21 | 130.41 | (1.20) | 129.21 |
Diluted Earnings Per Share (cent) | 62.45 | – | 62.45 | 128.67 | (1.17) | 127.50 |
2024 | 2023 | |
Weighted average number of ordinary shares in issue | 260,554,311 | 266,548,048 |
Shares deemed to be issued for no consideration in respect of share awards | 3,181,275 | 3,594,033 |
Weighted average number of shares used in the calculation of Diluted Earnings Per Share | 263,735,586 | 270,142,081 |
2024 | 2023 | ||
Notes | $m | $m | |
Equity dividends to shareholders | |||
Final – paid EUR 21.21c per ordinary share (2023: EUR 19.28c) | 60.2 | 57.6 | |
Interim – paid EUR 15.64c per ordinary share (2023: EUR 14.22c) | 45.2 | 39.9 | |
Total | 105.4 | 97.5 | |
Reconciliation to Group statement of cash flows and Group statement of changes in equity | |||
Dividends to shareholders | 105.4 | 97.5 | |
Waived dividends in relation to own shares | (0.6) | (0.3) | |
Dividend Withholding Tax refund | (0.4) | – | |
Total dividends paid to equity holders of the Company | 24 | 104.4 | 97.2 |
Equity dividends recommended | |||
Final 2024– proposed EUR 23.33c per ordinary share (2023: EUR 21.21c) | 62.2 | 62.1 |
Land and | Plant and | Motor | |||
buildings | equipment | Vehicles | Total | ||
Notes | $m | $m | $m | $m | |
Year ended 4 January 2025 | |||||
Opening carrying amount | 241.9 | 273.0 | 0.2 | 515.1 | |
Exchange differences | (2.5) | (1.3) | – | (3.8) | |
Acquisitions | 34 | – | 11.2 | – | 11.2 |
Additions | 17.7 | 38.5 | 0.6 | 56.8 | |
Depreciation charge | 5/32(a) | (12.3) | (39.7) | (0.2) | (52.2) |
Reclassification | 0.1 | (0.6) | 0.5 | – | |
Disposal of assets | (3.6) | (0.8) | – | (4.4) | |
Impairment reversal | 5 | 1.0 | – | – | 1.0 |
Impairment | 5 | (1.8) | (0.2) | – | (2.0) |
Transferred to assets held for sale | 33 | (2.8) | (0.3) | – | (3.1) |
Closing carrying amount | 237.7 | 279.8 | 1.1 | 518.6 | |
At 4 January 2025 | |||||
Cost | 369.6 | 755.4 | 3.9 | 1,128.9 | |
Accumulated depreciation and impairment | (131.9) | (475.6) | (2.8) | (610.3) | |
Carrying amount | 237.7 | 279.8 | 1.1 | 518.6 | |
Year ended 30 December 2023 | |||||
Opening carrying amount | 239.2 | 271.5 | 0.1 | 510.8 | |
Exchange differences | 0.9 | 0.9 | 0.2 | 2.0 | |
Acquisitions | 5.6 | 5.8 | – | 11.4 | |
Additions | 4.7 | 37.1 | – | 41.8 | |
Depreciation charge | 5/32(a) | (11.9) | (37.7) | (0.1) | (49.7) |
Reclassification | 3.4 | (3.4) | – | – | |
Disposal of assets | – | (1.2) | – | (1.2) | |
Closing carrying amount | 241.9 | 273.0 | 0.2 | 515.1 | |
At 30 December 2023 | |||||
Cost | 385.5 | 736.9 | 3.5 | 1,125.9 | |
Accumulated depreciation and impairment | (143.6) | (463.9) | (3.3) | (610.8) | |
Carrying amount | 241.9 | 273.0 | 0.2 | 515.1 |
Land and | Plant and | Motor | |||
buildings | equipment | vehicles | Total | ||
Notes | $m | $m | $m | $m | |
Year ended 4 January 2025 | |||||
Opening carrying amount | 81.3 | 3.9 | 3.1 | 88.3 | |
Exchange differences | (0.7) | 0.1 | (0.1) | (0.7) | |
Acquisitions | 34 | 2.3 | – | – | 2.3 |
Additions | 9.0 | 3.6 | 4.1 | 16.7 | |
Disposals | – | (0.2) | – | (0.2) | |
Remeasurements | 4.2 | 0.9 | (0.3) | 4.8 | |
Reclassification | (0.3) | – | 0.3 | – | |
Depreciation charge | 4/5/32(a) | (16.3) | (3.1) | (2.5) | (21.9) |
Impairment | 5 | (0.8) | – | (0.1) | (0.9) |
Transferred to assets held for sale | 33 | (1.3) | – | (0.1) | (1.4) |
Closing carrying amount | 77.4 | 5.2 | 4.4 | 87.0 | |
At 4 January 2025 | |||||
Cost | 140.9 | 12.9 | 10.7 | 164.5 | |
Accumulated depreciation and impairment | (63.5) | (7.7) | (6.3) | (77.5) | |
Carrying amount | 77.4 | 5.2 | 4.4 | 87.0 | |
Year ended 30 December 2023 | |||||
Opening carrying amount | 91.8 | 5.3 | 3.6 | 100.7 | |
Exchange differences | 0.3 | – | – | 0.3 | |
Acquisitions | 1.1 | 0.1 | – | 1.2 | |
Additions | 0.6 | 1.3 | 1.7 | 3.6 | |
Disposals | (1.3) | (0.1) | – | (1.4) | |
Remeasurements | 3.6 | – | – | 3.6 | |
Depreciation charge | 5/32(a) | (14.8) | (2.7) | (2.2) | (19.7) |
Closing carrying amount | 81.3 | 3.9 | 3.1 | 88.3 | |
At 30 December 2023 | |||||
Cost | 129.6 | 9.8 | 9.7 | 149.1 | |
Accumulated depreciation and impairment | (48.3) | (5.9) | (6.6) | (60.8) | |
Carrying amount | 81.3 | 3.9 | 3.1 | 88.3 |
2024 | 2023 | ||
Notes | $m | $m | |
Depreciation charge of right-of-use assets | 5 | 21.9 | 19.7 |
Impairment of right-of-use assets | 5 | 0.9 | – |
Interest expense on lease liabilities | 10 | 3.0 | 2.7 |
Expense relating to short-term leases | 3.5 | 4.2 | |
Expense relating to variable lease payments not included in lease liabilities | 0.1 | 0.1 |
2024 | 2023 | ||
Notes | $m | $m | |
Current | 20.8 | 20.1 | |
Non-current | 85.1 | 89.3 | |
Total | 30(c)/32(c) | 105.9 | 109.4 |
Brands | ||||||
and other | Software | Development | ||||
Goodwill | intangibles | costs | costs | Total | ||
Notes | $m | $m | $m | $m | $m | |
Year ended 4 January 2025 | ||||||
Opening carrying amount | 727.4 | 699.5 | 88.2 | 22.2 | 1,537.3 | |
Exchange differences | (4.3) | (2.4) | (3.7) | 0.2 | (10.2) | |
Acquisitions | 144.8 | 127.0 | – | – | 271.8 | |
Additions | – | – | 19.3 | 13.5 | 32.8 | |
Disposals | – | – | (0.2) | (0.3) | (0.5) | |
Amortisation | 4/5/32(a) | – | (49.9) | (18.9) | (13.3) | (82.1) |
Impairment | 5 | (30.8) | (95.4) | (8.3) | – | (134.5) |
Transferred to assets held for sale | 33 | – | (6.2) | (0.2) | (0.2) | (6.6) |
Closing carrying amount | 837.1 | 672.6 | 76.2 | 22.1 | 1,608.0 | |
At 4 January 2025 | ||||||
Cost | 837.1 | 1,231.1 | 169.3 | 74.4 | 2,311.9 | |
Accumulated amortisation and impairment | – | (558.5) | (93.1) | (52.3) | (703.9) | |
Carrying amount | 837.1 | 672.6 | 76.2 | 22.1 | 1,608.0 | |
Year ended 30 December 2023 | ||||||
Opening carrying amount | 712.9 | 726.8 | 85.3 | 23.8 | 1,548.8 | |
Exchange differences | 3.1 | 1.4 | 2.5 | – | 7.0 | |
Acquisitions | 11.4 | 17.8 | – | – | 29.2 | |
Additions | – | – | 20.1 | 12.1 | 32.2 | |
Disposals | – | – | – | (0.3) | (0.3) | |
Amortisation | 4/5/32(a) | – | (46.5) | (19.7) | (13.4) | (79.6) |
Closing carrying amount | 727.4 | 699.5 | 88.2 | 22.2 | 1,537.3 | |
At 30 December 2023 | ||||||
Cost | 727.4 | 1,121.9 | 200.2 | 68.2 | 2,117.7 | |
Accumulated amortisation and impairment | – | (422.4) | (112.0) | (46.0) | (580.4) | |
Carrying amount | 727.4 | 699.5 | 88.2 | 22.2 | 1,537.3 |
Recipes, Know- | |||||
Customer | how | ||||
Brands | relationships | and other | Total | ||
Notes | $m | $m | $m | $m | |
Year ended 4 January 2025 | |||||
Opening carrying amount | 482.8 | 168.9 | 47.8 | 699.5 | |
Exchange differences | (2.0) | (0.3) | (0.1) | (2.4) | |
Acquisitions | 34 | 8.0 | 17.0 | 102.0 | 127.0 |
Amortisation | (14.5) | (26.8) | (8.6) | (49.9) | |
Impairment | (73.6) | (21.8) | – | (95.4) | |
Transferred to assets held for sale | (6.2) | – | – | (6.2) | |
Closing carrying amount | 394.5 | 137.0 | 141.1 | 672.6 | |
At 4 January 2025 | |||||
Cost | 573.1 | 489.9 | 168.1 | 1,231.1 | |
Accumulated amortisation and impairment | (178.6) | (352.9) | (27.0) | (558.5) | |
Carrying amount | 394.5 | 137.0 | 141.1 | 672.6 | |
Year ended 30 December 2023 | |||||
Opening carrying amount | 491.1 | 194.4 | 41.3 | 726.8 | |
Exchange differences | 1.1 | 0.3 | – | 1.4 | |
Acquisitions | 3.3 | 4.5 | 10.0 | 17.8 | |
Reclassification | 0.2 | (0.1) | (0.1) | – | |
Amortisation | (12.9) | (30.2) | (3.4) | (46.5) | |
Closing carrying amount | 482.8 | 168.9 | 47.8 | 699.5 | |
At 30 December 2023 | |||||
Cost | 580.5 | 475.2 | 66.2 | 1,121.9 | |
Accumulated amortisation and impairment | (97.7) | (306.3) | (18.4) | (422.4) | |
Carrying amount | 482.8 | 168.9 | 47.8 | 699.5 |
2024 | 2023 | |||
Average | Average | |||
remaining | remaining | |||
Carrying | amortisation | Carrying | amortisation | |
amount | period | amount | period | |
$m | Years | $m | Years | |
Brands | ||||
Glanbia Performance Nutrition – BSN | 41.5 | 26 | 43.1 | 27 |
Glanbia Performance Nutrition – Isopure | 53.8 | 30 | 55.6 | 31 |
Glanbia Performance Nutrition – think! | 66.5 | 31 | 68.7 | 32 |
Glanbia Performance Nutrition – Amazing Grass | 32.8 | 32 | 33.8 | 33 |
Glanbia Performance Nutrition – SlimFast North America | 25.7 | 34 | 98.3 | 35 |
Glanbia Performance Nutrition – SlimFast International | 19.8 | 34 | 20.4 | 35 |
Customer relationships | ||||
Glanbia Performance Nutrition – think! | 22.1 | 4 | 28.3 | 5 |
Glanbia Performance Nutrition – Amazing Grass | 19.2 | 7 | 21.9 | 8 |
Glanbia Nutritionals – Sterling Technology | 27.2 | 12 | 29.5 | 13 |
Know-How | ||||
Glanbia Nutritionals – Flavours | 97.4 | 15 | – | – |
2024 | 2023 | |
Carrying amount | $m | $m |
Brands | ||
Glanbia Performance Nutrition – Optimum Nutrition | 122.7 | 122.7 |
2024 | 2023 | |
Number of | Number of | |
CGUs | CGUs | |
Glanbia Performance Nutrition operating segment | ||
Americas | 6 | 1 |
International | 6 | 3 |
Glanbia Nutritionals operating segment | ||
Nutritional Solutions | 1 | 1 |
Total | 13 | 5 |
2024 | 2023 | |||
$m | Discount rate | $m | Discount rate | |
Americas | 412.5 | 9.42% | 412.5 | 8.33% |
International | 92.9 | 10.03% | 65.2 | 7.97% |
Nutritional Solutions | 331.7 | 9.09% | 176.5 | 8.25% |
Direct-to-Consumer (Body & Fit)* | – | – | 31.5 | 6.73% |
Direct-to-Consumer (LevlUp)** | – | – | 30.3 | 6.23% |
At the end of the year | 837.1 | 716.0 |
2024 | 2023 | |||
$m | Discount rate | $m | Discount rate | |
Optimum Nutrition Americas | 113.1 | 9.42% | 113.1 | 8.33% |
Optimum Nutrition International | 9.6 | 10.03% | 9.6 | 7.97% |
At the end of the year | 122.7 | 122.7 |
2024 | 2023 | ||
Notes | $m | $m | |
At the beginning of the year | 159.3 | 225.3 | |
Share of profit after tax (post-exceptional) | 0.1 | 12.5 | |
Share of OCI – remeasurements on defined benefit plan, net of deferred tax | 24 | – | 0.1 |
Share of OCI – fair value movement on cash flow hedges, net of deferred tax | 23(c) | (0.1) | (2.5) |
Dividends received | 35 | (5.0) | (32.0) |
Income tax movement | 3.2 | 6.1 | |
Transferred to assets held for sale* | – | (51.0) | |
Exchange differences | – | 0.8 | |
At the end of the year | 157.5 | 159.3 |
2024 | 2023 | |
$m | $m | |
Summarised balance sheet (100%): | ||
Non-current assets | 709.3 | 745.9 |
Current assets | ||
Cash and cash equivalents | 8.7 | 19.2 |
Other current assets | 293.6 | 229.3 |
302.3 | 248.5 | |
Non-current liabilities | ||
Borrowings | (450.0) | (475.0) |
Other non-current liabilities | (7.9) | (7.7) |
(457.9) | (482.7) | |
Current liabilities | ||
Other current liabilities | (238.7) | (192.9) |
(238.7) | (192.9) | |
Net assets (100%) | 315.0 | 318.8 |
Net assets attributable to equity holders of the Company | 315.0 | 318.8 |
Reconciliation to carrying amount: | ||
Group’s share of net assets | 157.5 | 159.4 |
Adjustment in respect of unrealised profit in stock to the Group | – | (0.1) |
Carrying amount | 157.5 | 159.3 |
Summarised income statement (100%): | ||
Revenue | 1,939.6 | 1,875.7 |
Depreciation | (43.4) | (42.6) |
Amortisation | (2.5) | (2.5) |
Interest expense | (20.8) | (24.1) |
Tax | – | (0.8) |
Profit after tax | 0.1 | 28.7 |
Other comprehensive income | (0.1) | (5.3) |
Total comprehensive income | – | 23.4 |
Profit after tax attributable to equity holders of the Company | 0.1 | 28.7 |
Total comprehensive income attributable to equity holders of the Company | – | 23.4 |
Reconciliation to the Group’s share of total comprehensive income: | ||
Group’s share of total comprehensive income | – | 11.7 |
Adjustment in respect of unrealised profit on sales to the Group | 0.1 | – |
Group’s share of total comprehensive income | 0.1 | 11.7 |
Dividends received by Group | 5.0 | 27.5 |
2024 | 2023 | |
$m | $m | |
Equity instruments designated at FVOCI | ||
The BDO Development Capital Fund | – | 1.7 |
Others | 0.9 | 0.9 |
Other financial assets | 0.9 | 2.6 |
2024 | 2023 | ||
Notes | $m | $m | |
At the beginning of the year | 2.6 | 2.3 | |
Disposals/redemption | (1.6) | (0.1) | |
Fair value adjustment | 23 | – | 0.3 |
Exchange differences | (0.1) | 0.1 | |
At the end of the year | 0.9 | 2.6 |
2024 | 2023 | ||
Notes | $m | $m | |
Current | |||
Trade receivables | 341.4 | 450.7 | |
Less: loss allowance | 30(b) | (9.7) | (10.0) |
Trade receivables – net | 331.7 | 440.7 | |
Receivables from joint ventures | 0.5 | 0.2 | |
Receivables from other related parties | 3.0 | 7.2 | |
Value added tax | 5.1 | 4.3 | |
Prepayments | 25.9 | 27.2 | |
Other receivables | 25.3 | 22.2 | |
391.5 | 501.8 |
Pound | Australian | |||||
US dollar | euro | sterling | dollar | Other | Total | |
$m | $m | $m | $m | $m | $m | |
At 4 January 2025 | 306.9 | 36.9 | 25.9 | 5.8 | 16.0 | 391.5 |
At 30 December 2023 | 405.3 | 42.2 | 33.6 | 5.2 | 15.5 | 501.8 |
2024 | 2023 | |
$m | $m | |
Raw materials | 226.6 | 167.0 |
Work in progress | 19.1 | 19.0 |
Finished goods | 348.8 | 326.5 |
Consumables | 40.3 | 37.7 |
634.8 | 550.2 |
2024 | 2023 | ||
Notes | $m | $m | |
Cost of inventories recognised as an expense in cost of goods sold* | 5 | 2,163.8 | 3,850.7 |
Write down of inventory to net realisable value during the year | 38.6 | 34.1 | |
Previous write downs of inventories reversed during the year** | (10.9) | (15.7) | |
27.7 | 18.4 |
2024 | 2023 | ||
Notes | $m | $m | |
Cash at bank and in hand | 386.8 | 404.5 | |
Short term bank deposits | 30.2 | 9.2 | |
Cash and cash equivalents in the Group balance sheet | 417.0 | 413.7 | |
Bank overdrafts used for cash management purposes | 25 | (300.8) | (108.9) |
Cash and cash equivalents in the Group statement of cash flows | 25 | 116.2 | 304.8 |
Number | Ordinary | Share | ||
of shares | shares | premium | Total | |
(thousands) | $m | $m | $m | |
At 31 December 2023 | 265,072 | 19.8 | 109.9 | 129.7 |
Cancellation of own shares | (6,171) | (0.4) | – | (0.4) |
At 4 January 2025 | 258,901 | 19.4 | 109.9 | 129.3 |
At 1 January 2023 | 272,287 | 20.3 | 109.9 | 130.2 |
Cancellation of own shares | (7,215) | (0.5) | – | (0.5) |
At 30 December 2023 | 265,072 | 19.8 | 109.9 | 129.7 |
Capital | Share- | ||||||
and | Own | based | |||||
merger | Currency | Hedging | shares | payment | FVOCI | ||
reserve | reserve | reserve | reserve | reserve | reserve | Total | |
$m | $m | $m | $m | $m | $m | $m | |
note (a) | note (b) | note (c) | note (d) | note (e) | note (f) | ||
Balance at 31 December 2023 | 136.7 | 30.4 | 4.5 | (37.5) | 37.8 | 0.2 | 172.1 |
Currency translation differences | – | (5.5) | – | – | – | – | (5.5) |
Net investment hedge | – | (7.0) | – | – | – | – | (7.0) |
Revaluation – gross | – | – | 0.8 | – | – | – | 0.8 |
Reclassification to profit or loss – gross | – | – | 0.8 | – | – | – | 0.8 |
Deferred tax | – | – | (0.2) | – | – | – | (0.2) |
Net change in OCI | – | (12.5) | 1.4 | – | – | – | (11.1) |
Purchase of own shares | – | – | – | (129.8) | – | – | (129.8) |
Cancellation of own shares | 0.4 | – | – | 111.0 | – | – | 111.4 |
Share-based payment expense | – | – | – | – | 18.2 | – | 18.2 |
Transfer on exercise, vesting or expiry | |||||||
of share-based payments | – | – | – | 33.1 | (25.6) | – | 7.5 |
Balance at 4 January 2025 | 137.1 | 17.9 | 5.9 | (23.2) | 30.4 | 0.2 | 168.3 |
Balance at 1 January 2023 | 136.2 | 12.6 | 9.7 | (22.0) | 31.4 | – | 167.9 |
Currency translation differences | – | 4.4 | – | – | – | – | 4.4 |
Net investment hedge | – | 3.5 | – | – | – | – | 3.5 |
Revaluation – gross | – | – | (6.5) | – | – | 0.3 | (6.2) |
Reclassification to profit or loss – gross | – | – | (0.3) | – | – | – | (0.3) |
Deferred tax | – | – | 1.4 | – | – | (0.1) | 1.3 |
Net change in OCI | – | 7.9 | (5.4) | – | – | 0.2 | 2.7 |
Purchase of own shares | – | – | – | (148.1) | – | – | (148.1) |
Cancellation of own shares | 0.5 | – | – | 108.7 | – | – | 109.2 |
Share-based payment expense | – | – | – | – | 24.5 | – | 24.5 |
Transfer on exercise, vesting or expiry | |||||||
of share-based payments | – | – | – | 23.9 | (18.1) | – | 5.8 |
Transfer to Group income statement* | – | 9.9 | 0.2 | – | – | – | 10.1 |
Balance at 30 December 2023 | 136.7 | 30.4 | 4.5 | (37.5) | 37.8 | 0.2 | 172.1 |
$m | |
Share premium representing excess of fair value over nominal value of ordinary shares issued in connection with the | |
merger of Avonmore Foods plc and Waterford Foods plc | 411.7 |
Merger reserve adjustment | (379.1) |
Share premium and other reserves relating to nominal value of shares in Waterford Foods plc | 98.5 |
At the beginning and end of the current and prior year | 131.1 |
Joint ventures | Group | Total | |
$m | $m | $m | |
Balance at 31 December 2023 | 5.0 | (0.5) | 4.5 |
Revaluation – gross | |||
– Foreign exchange contracts (currency risk) | – | 1.1 | 1.1 |
– Interest rate swaps (interest rate risk) | (0.1) | – | (0.1) |
– Commodity contracts- (commodity price risk) | (0.3) | 0.1 | (0.2) |
Recognised in OCI | (0.4) | 1.2 | 0.8 |
Reclassification to profit or loss – gross | |||
– Foreign exchange contracts (currency risk) | – | 0.5 | 0.5 |
– Commodity contracts- (commodity price risk) | 0.3 | – | 0.3 |
Reclassified from OCI to profit or loss | 0.3 | 0.5 | 0.8 |
Deferred tax | – | (0.2) | (0.2) |
Net change in OCI | (0.1) | 1.5 | 1.4 |
Balance at 4 January 2025 | 4.9 | 1.0 | 5.9 |
Balance at 1 January 2023 | 7.3 | 2.4 | 9.7 |
Changes in fair value – gross | |||
– Foreign exchange contracts (currency risk) | 0.1 | – | 0.1 |
– Interest rate swaps (interest rate risk) | (3.6) | (3.0) | (6.6) |
Recognised in OCI | (3.5) | (3.0) | (6.5) |
Reclassification to profit or loss – gross | |||
– Foreign exchange contracts (currency risk) | – | (0.3) | (0.3) |
Reclassified from OCI to profit or loss | – | (0.3) | (0.3) |
Deferred tax | 1.0 | 0.4 | 1.4 |
Net change in OCI | (2.5) | (2.9) | (5.4) |
Transfer to Group Income Statement | 0.2 | – | 0.2 |
Balance at 30 December 2023 | 5.0 | (0.5) | 4.5 |
2024 | 2023 | |||||
Value | Nominal value | Number of | Value | Nominal value | Number of | |
$m | $m | Shares | $m | $m | Shares | |
At the beginning of the year | 37.5 | 0.1 | 2,368,126 | 22.0 | 0.1 | 1,711,322 |
Purchased by Employee Share (Scheme) Trust | 18.4 | 0.1 | 1,008,071 | 39.4 | 0.1 | 2,412,343 |
Purchased under share buyback | 111.4 | 0.4 | 6,200,309 | 108.7 | 0.5 | 7,215,827 |
Allocated under Employee Share (Scheme) Trust | (33.1) | (0.1) | (2,032,665) | (23.9) | (0.1) | (1,755,539) |
Cancelled under share buyback | (111.0) | (0.4) | (6,170,309) | (108.7) | (0.5) | (7,215,827) |
At the end of the year | 23.2 | 0.1 | 1,373,532 | 37.5 | 0.1 | 2,368,126 |
2024 | 2023 | ||
Notes | $m | $m | |
At the beginning of the year | 1,830.8 | 1,686.2 | |
Profit for the year attributable to equity holders of the Company | 164.7 | 344.4 | |
Other comprehensive income | |||
– Remeasurements on defined benefit plans | 4.6 | 1.7 | |
– Deferred tax on remeasurements on defined benefit plans | 26 | (0.5) | (0.2) |
– Share of remeasurements on defined benefit plans from joint ventures, net of deferred tax | 17 | – | 0.1 |
4.1 | 1.6 | ||
Dividends | 13 | (104.4) | (97.2) |
Cancellation of own shares | 23(d) | (111.0) | (108.7) |
Transfer on exercise, vesting or expiry of share-based payments | 23 | (7.5) | (5.8) |
Deferred tax on share-based payments | 26 | (1.5) | 2.1 |
Derecognition of NCI | – | 8.2 | |
At the end of the year | 1,775.2 | 1,830.8 |
2024 | 2023 | ||
Notes | $m | $m | |
Non-current | |||
Bank borrowings | 177. 2 | 178.5 | |
Private placement debt | 375.0 | 375.0 | |
29(b) | 552.2 | 553.5 | |
Current | |||
Bank overdrafts | 21 | 300.8 | 108.9 |
Total borrowings | 30(b)/30(c) | 853.0 | 662.4 |
2024 | 2023 | |||||
Undrawn | Undrawn | Undrawn | Undrawn | |||
committed | uncommitted | committed | uncommitted | |||
Borrowings | facilities | facilities | Borrowings | facilities | facilities | |
$m | $m | $m | $m | $m | $m | |
Less than 1 year | 300.8 | – | 16.3 | 108.9 | – | 16.9 |
Between 1 and 2 years | – | – | – | - | – | – |
Between 2 and 5 years | 277.2 | 720.8 | – | 278.5 | 767.2 | – |
More than 5 years | 275.0 | – | – | 275.0 | – | – |
853.0 | 720.8 | 16.3 | 662.4 | 767.2 | 16.9 |
2024 | 2023 | ||
Notes | $m | $m | |
Private placement debt | 375.0 | 375.0 | |
Bank borrowings | 169.0 | 169.0 | |
Not subject to interest rate changes* | 544.0 | 544.0 | |
Bank borrowings | 8.2 | 9.5 | |
Cash and cash equivalents net of bank overdrafts | 21 | (116.2) | (304.8) |
Subject to interest rate changes* | (108.0) | (295.3) | |
Net debt | 30(a) | 436.0 | 248.7 |
Cash and | ||||||
short-term | Private | |||||
bank deposits | Overdrafts | placement | ||||
$m | $m | Borrowings | debt | Total | ||
Notes | (note 21) | (note 21) | $m | $m | $m | |
At 31 December 2023 | (413.7) | 108.9 | 178.5 | 375.0 | 248.7 | |
Drawdown of borrowings | 32(c) | – | – | 672.8 | – | 672.8 |
Repayment of borrowings | 32(c) | – | – | (673.3) | – | (673.3) |
Net change in cash and cash equivalents | (16.3) | 206.5 | – | – | 190.2 | |
Exchange differences | 13.0 | (14.6) | (0.8) | – | (2.4) | |
At 4 January 2025 | (417.0) | 300.8 | 177.2 | 375.0 | 436.0 | |
At 1 January 2023 | (467.9) | 275.4 | 307.5 | 375.0 | 490.0 | |
Drawdown of borrowings | 32(c) | – | – | 140.8 | – | 140.8 |
Repayment of borrowings | 32(c) | – | – | (271.6) | – | (271.6) |
Net change in cash and cash equivalents | 58.9 | (174.9) | – | – | (116.0) | |
Exchange differences | (4.7) | 8.4 | 1.8 | – | 5.5 | |
At 30 December 2023 | (413.7) | 108.9 | 178.5 | 375.0 | 248.7 |
US | Pound | ||||
dollar | euro | sterling | Other | Total | |
$m | $m | $m | $m | $m | |
At 4 January 2025 | |||||
Borrowings | (695.3) | (144.1) | (13.6) | – | (853.0) |
Cash and cash equivalents (note 21) | 212.4 | 110.3 | 24.8 | 69.5 | 417.0 |
(482.9) | (33.8) | 11.2 | 69.5 | (436.0) | |
At 30 December 2023 | |||||
Borrowings | (561.4) | (81.7) | (9.5) | (9.8) | (662.4) |
Cash and cash equivalents (note 21) | 217.4 | 106.4 | 19.7 | 70.2 | 413.7 |
(344.0) | 24.7 | 10.2 | 60.4 | (248.7) |
2024 | 2023 | |||||
Deferred tax | Deferred tax | Deferred tax | Deferred tax | |||
assets | liabilities | Net | assets | liabilities | Net | |
$m | $m | $m | $m | $m | $m | |
Deferred tax assets/(liabilities) before offset | 80.6 | (181.8) | (101.2) | 78.1 | (210.8) | (132.7) |
Offset of deferred tax | (77.2) | 77.2 | – | (72.9) | 72.9 | – |
Deferred tax assets/(liabilities) after offset | 3.4 | (104.6) | (101.2) | 5.2 | (137.9) | (132.7) |
2024 | 2023 | ||
Notes | $m | $m | |
At the beginning of the year | (132.7) | (133.3) | |
Income statement credit/(charge) | 11 | 29.6 | (0.5) |
Deferred tax (charge)/credit to other comprehensive income | |||
– on remeasurement of defined benefit plans | 24 | (0.5) | (0.2) |
– on disposal/redemption of FVOCI financial assets | 23 | – | (0.1) |
– on fair value movements | 23(c) | (0.2) | 0.4 |
Deferred tax (charge)/credit to equity | |||
– on share-based payments | 24 | (1.5) | 2.1 |
Acquisition of subsidiaries and intellectual property | 1.4 | – | |
Exchange differences | 2.7 | (1.1) | |
At the end of the year | (101.2) | (132.7) |
Retirement | Other | |||||
benefit | employee | Lease | ||||
obligations | obligations | Tax losses | liabilities | Other | Total | |
$m | $m | $m | $m | $m | $m | |
At 31 December 2023 | 3.9 | 16.5 | 6.5 | 38.2 | 13.0 | 78.1 |
(Charge)/credit to income statement | 0.5 | 1.0 | (4.6) | 0.8 | (0.5) | (2.8) |
Charge to other comprehensive income | (0.5) | – | – | – | – | (0.5) |
Charge to equity | – | (1.5) | – | – | – | (1.5) |
Acquisition of subsidiaries and intellectual | ||||||
property | – | 0.1 | 4.0 | 1.2 | 2.5 | 7.8 |
Exchange differences | 0.1 | (0.5) | (0.2) | – | 0.1 | (0.5) |
At 4 January 2025 | 4.0 | 15.6 | 5.7 | 40.2 | 15.1 | 80.6 |
At 1 January 2023 | 3.4 | 18.5 | 4.4 | 40.9 | 21.3 | 88.5 |
(Charge)/credit to income statement | 0.8 | (4.3) | 1.9 | (2.7) | (7.9) | (12.2) |
Charge to other comprehensive income | (0.2) | – | – | – | (0.1) | (0.3) |
Credit to equity | – | 2.1 | – | – | – | 2.1 |
Exchange differences | (0.1) | 0.2 | 0.2 | – | (0.3) | – |
At 30 December 2023 | 3.9 | 16.5 | 6.5 | 38.2 | 13.0 | 78.1 |
Development | ||||||
Accelerated tax | Fair value | costs and other | Right-of-use | |||
depreciation | gain | intangibles | assets | Other | Total | |
$m | $m | $m | $m | $m | $m | |
At 31 December 2023 | (66.9) | – | (67.0) | (31.8) | (45.1) | (210.8) |
Credit/(charge) to income statement | 2.6 | – | 31.0 | (1.3) | 0.1 | 32.4 |
Charge to other comprehensive income | – | (0.2) | – | – | – | (0.2) |
Acquisition of subsidiaries and intellectual | ||||||
property | (0.4) | – | (4.8) | (1.2) | – | (6.4) |
Exchange differences | 0.1 | – | 0.5 | – | 2.6 | 3.2 |
At 4 January 2025 | (64.6) | (0.2) | (40.3) | (34.3) | (42.4) | (181.8) |
At 1 January 2023 | (76.8) | (1.1) | (79.2) | (34.0) | (30.7) | (221.8) |
Credit/(charge) to income statement | 9.9 | 0.7 | 12.2 | 2.2 | (13.3) | 11.7 |
Credit to other comprehensive income | – | 0.4 | – | – | – | 0.4 |
Exchange differences | – | – | – | – | (1.1) | (1.1) |
At 30 December 2023 | (66.9) | – | (67.0) | (31.8) | (45.1) | (210.8) |
Restructuring | ||||
and portfolio | Property | |||
related | and lease | Legal and | ||
re-organisation | commitments | operational | ||
$m | $m | $m | Total | |
note (a) | note (b) | note (c) | $m | |
Balance at 31 December 2023 – non-current | – | 4.3 | – | 4.3 |
Balance at 31 December 2023– current | 7.3 | 2.5 | 13.3 | 23.1 |
Amount provided for in the year | 1.8 | – | 2.1 | 3.9 |
Utilised in the year | (4.2) | (0.6) | (2.7) | (7.5) |
Unused amounts reversed in the year | – | (0.1) | (8.0) | (8.1) |
Unwinding of discount | – | 0.1 | – | 0.1 |
Exchange differences | (0.3) | (0.2) | (0.3) | (0.8) |
Balance at 4 January 2025 | 4.6 | 6.0 | 4.4 | 15.0 |
Non-current | – | 4.3 | – | 4.3 |
Current | 4.6 | 1.7 | 4.4 | 10.7 |
4.6 | 6.0 | 4.4 | 15.0 |
2024 | 2023 | ||
Notes | $m | $m | |
Current | |||
Trade payables | 30(b) | 344.6 | 280.2 |
Amounts due to joint ventures | 30(b) | 23.5 | 115.7 |
Amounts due to other related parties | 30(b) | 12.3 | 8.3 |
Social insurance costs | 5.9 | 7.6 | |
Accrued expenses | 225.4 | 247.3 | |
611.7 | 659.1 |
2024 | 2024 | 2023 | 2023 | |
Assets | Liabilities | Assets | Liabilities | |
$m | $m | $m | $m | |
Cross currency swaps – fair value through income statement | 0.4 | – | – | (1.5) |
Foreign exchange contracts – cash flow hedges (currency risk) | 1.0 | – | – | (0.5) |
1.4 | – | – | (2.0) | |
Non-current | – | – | – | – |
Current | 1.4 | – | – | (2.0) |
1.4 | – | – | (2.0) |
2024 | 2023 | ||
Changes in fair value recognised in other comprehensive income | Notes | $m | $m |
Foreign exchange contracts | 23(c) | 1.1 | – |
Interest rate swaps | 23(c) | – | (3.0) |
Commodity contracts | 23(c) | 0.1 | – |
1.2 | (3.0) | ||
Reclassified from cash flow hedge reserve to the Group income statement | |||
Foreign exchange contracts | 23(c) | 0.5 | (0.3) |
2024 | 2023 | ||||
Carrying | Carrying | ||||
amount | Fair value | amount | Fair value | ||
Notes | $m | $m | $m | $m | |
Financial liabilities | |||||
– Non-current borrowings | 25 | 552.2 | 493.6 | 553.5 | 496.8 |
Fair value | 2024 | 2023 | ||
Notes | hierarchy | $m | $m | |
Assets | ||||
Foreign exchange contracts – cash flow hedges | (a) | Level 2 | 1.0 | – |
Cross currency swaps – fair value through income statement | (b) | Level 2 | 0.4 | – |
Equity instrument designated at FVOCI – The BDO Development Capital Fund | (c) | Level 2 | – | 1.7 |
Liabilities | ||||
Foreign exchange contracts – cash flow hedges | (a) | Level 2 | – | (0.5) |
Cross currency swaps – fair value through income statement | (b) | Level 2 | – | (1.5) |
Contingent consideration payable – Flavor Producers, LLC | (d) | Level 3 | – | – |
Contingent | |
consideration | |
$m | |
At 1 January 2023 | (27.0) |
Remeasurements | 0.2 |
Settlements | 26.8 |
At 30 December 2023 | – |
2024 | 2023 | ||
Notes | $m | $m | |
Equity | 2,072.8 | 2,132.6 | |
Net debt | 25 | 436.0 | 248.7 |
Total capital | 2,508.8 | 2,381.3 |
2024 | 2023 | |
+/-5% change in US dollar/euro exchange rate | $m | $m |
Impact on profit before tax* | -/+5.4 | -/+4.9 |
Impact on total equity** | -/+6.8 | -/+12.5 |
2024 | 2023 | |
+/-1% change in market interest rates* | $m | $m |
Impact on profit before tax | -/+0.1 | -/+0.1 |
Impact on total equity | -/+0.1 | -/+0.1 |
Between | Between | |||||
Less than | 1 and 2 | 2 and 5 | More than | |||
1 year | years | years | 5 years | Total | ||
Notes | $m | $m | $m | $m | $m | |
At 4 January 2025 | ||||||
Non-derivative financial liabilities | ||||||
Trade payables | 28 | 344.6 | – | – | – | 344.6 |
Amounts due to joint venture | 28 | 23.5 | – | – | – | 23.5 |
Amounts due to other related parties | 28 | 12.3 | – | – | – | 12.3 |
Lease liabilities | 22.8 | 19.7 | 38.7 | 33.9 | 115.1 | |
Interest-bearing borrowings | 25 | 300.8 | – | 277.2 | 275.0 | 853.0 |
Projected interest payments on interest-bearing borrowings* | 18.3 | 17.8 | 33.8 | 13.9 | 83.8 | |
722.3 | 37.5 | 349.7 | 322.8 | 1,432.3 | ||
Derivative financial liabilities | – | – | – | – | – | |
At 30 December 2023 | ||||||
Non-derivative financial liabilities | ||||||
Trade payables | 28 | 280.2 | – | – | – | 280.2 |
Amounts due to joint ventures | 28 | 115.7 | – | – | – | 115.7 |
Amounts due to other related parties | 28 | 8.3 | – | – | – | 8.3 |
Lease liabilities | 22.3 | 17.2 | 39.3 | 41.2 | 120.0 | |
Interest-bearing borrowings | 25 | 108.9 | – | 278.5 | 275.0 | 662.4 |
Projected interest payments on interest-bearing borrowings* | 18.8 | 18.0 | 44.6 | 21.5 | 102.9 | |
554.2 | 35.2 | 362.4 | 337.7 | 1,289.5 | ||
Derivative financial liabilities | 2.0 | – | – | – | 2.0 |
2024 | 2023 | ||
Notes | $m | $m | |
At the beginning of the year | 10.0 | 13.8 | |
Increase in loss allowance recognised during the year | 1.1 | 2.6 | |
Receivables written off during the year as uncollectible | (1.3) | (1.2) | |
Unused amounts reversed | (0.1) | (5.2) | |
At the end of the year | 19 | 9.7 | 10.0 |
2024 | 2023 | |
$m | $m | |
Past due | ||
Less than 30 days | 20.5 | 15.4 |
1 to 3 months | 4.1 | 3.9 |
4 to 6 months | 1.7 | 1.3 |
Over 6 months | 6.6 | 5.2 |
32.9 | 25.8 | |
Less: expected credit loss allowance | (9.7) | (10.0) |
Total | 23.2 | 15.8 |
2024 | 2023 | ||
Notes | $m | $m | |
Financial assets measured at amortised cost | |||
Trade receivables and receivables from related parties | 335.2 | 448.1 | |
Financial liabilities measured at amortised cost | |||
Borrowings | 25 | (853.0) | (662.4) |
Trade payables and amounts due to related parties | (380.4) | (404.2) | |
Lease liabilities | 15 | (105.9) | (109.4) |
(1,339.3) | (1,176.0) | ||
Equity instruments designated at FVOCI | 18 | 0.9 | 2.6 |
Net derivative asset/(liability) | 1.4 | (2.0) |
2024 | 2023 | |
$m | $m | |
Property, plant and equipment | 6.1 | 7.2 |
Intangible assets | 0.1 | 1.0 |
2024 | 2023 | ||
Notes | $m | $m | |
Profit for the year | 164.7 | 344.5 | |
Exceptional items | 6 | 145.6 | (46.4) |
Income taxes | 59.1 | 46.5 | |
Profit before taxation | 369.4 | 344.6 | |
Share of results of joint ventures accounted for using the equity method | (0.1) | (12.5) | |
Finance costs | 10 | 32.2 | 22.1 |
Finance income | 10 | (5.4) | (9.8) |
Amortisation of intangible assets | 16 | 82.1 | 79.6 |
Depreciation of property, plant and equipment | 14 | 52.2 | 49.7 |
Depreciation of right-of-use assets | 15 | 21.9 | 19.7 |
Reversal of impairment of property, plant and equipment | 14 | (1.0) | - |
Share-based payment expense | 9/23 | 18.2 | 24.5 |
Difference between pension charge and cash contributions | 0.1 | (2.7) | |
Net write down of inventories | 27.7 | 18.4 | |
Non-cash movement in/on: | |||
– provisions | (2.1) | 7.4 | |
– allowance for impairment of receivables | (0.3) | (3.8) | |
– cross currency swaps | (1.5) | 0.7 | |
– other financial assets | (0.7) | - | |
(Profit)/loss on disposal of property, plant and equipment | 5 | (0.3) | 1.2 |
Loss on disposal of intangible assets | 5 | 0.5 | - |
Operating cash flows before movement in working capital | 592.9 | 539.1 | |
(Increase)/decrease in inventories | 32(b) | (121.5) | 191.2 |
Decrease/(increase) in trade and other receivables | 32(b) | 116.0 | (91.1) |
Decrease in trade and other payables | 32(b) | (44.3) | (144.4) |
Decrease in provisions | 32(b) | (11.5) | (3.4) |
Cash generated from operating activities before exceptional items | 531.6 | 491.4 |
Trade and other | Trade and other | ||||
Inventories | receivables | payables | Provisions | Total | |
$m | $m | $m | $m | $m | |
2024 | (note 20) | (note 19) | (note 28) | (note 27) | |
At 31 December 2023 | 550.2 | 501.8 | (659.1) | (27.4) | 365.5 |
Exchange differences | (7.7) | (4.4) | 7.3 | 0.8 | (4.0) |
Arising on acquisition (note 34) | 8.4 | 14.5 | (8.2) | – | 14.7 |
Loans/amounts payable to joint ventures, interest accruals, capital creditors and other non-operating items | (37.6) | (4.4) | 4.0 | 0.1 | (37.9) |
Movement in working capital | 121.5 | (116.0) | 44.3 | 11.5 | 61.3 |
At 4 January 2025 | 634.8 | 391.5 | (611.7) | (15.0) | 399.6 |
2023 | |||||
At 1 January 2023 | 750.5 | 404.8 | (826.5) | (16.0) | 312.8 |
Exchange differences | 3.8 | 0.2 | (4.6) | (0.5) | (1.1) |
Arising on acquisition | 5.6 | 2.4 | (4.1) | – | 3.9 |
Loans/amounts payable to joint ventures, interest accruals, capital creditors and other non-operating items | (18.5) | 3.3 | 31.7 | (14.3) | 2.2 |
Movement in working capital | (191.2) | 91.1 | 144.4 | 3.4 | 47.7 |
At 30 December 2023 | 550.2 | 501.8 | (659.1) | (27.4) | 365.5 |
Private | Lease | ||||
Borrowings | Placement Debt | liabilities | |||
$m | $m | $m | Total | ||
2024 | Notes | (note 25) | (note 25) | (note 15) | $m |
At 31 December 2023 | 178.5 | 375.0 | 109.4 | 662.9 | |
Drawdown of borrowings | 25 | 672.8 | - | - | 672.8 |
Repayment of borrowings | 25 | (673.3) | - | - | (673.3) |
Leases | - | - | 18.6 | 18.6 | |
Payment of lease liabilities | - | - | (23.7) | (23.7) | |
Acquisitions | 34 | - | - | 2.3 | 2.3 |
Exchange differences | (0.8) | - | (0.7) | (1.5) | |
At 4 January 2025 | 177. 2 | 375.0 | 105.9 | 658.1 | |
2023 | |||||
At 1 January 2023 | 307.5 | 375.0 | 122.5 | 805.0 | |
Drawdown of borrowings | 25 | 140.8 | – | – | 140.8 |
Repayment of borrowings | 25 | (271.6) | – | – | (271.6) |
Leases | – | – | 5.3 | 5.3 | |
Payment of lease liabilities | – | – | (19.9) | (19.9) | |
Acquisitions | – | – | 1.1 | 1.1 | |
Exchange differences | 1.8 | – | 0.4 | 2.2 | |
At 30 December 2023 | 178.5 | 375.0 | 109.4 | 662.9 |
2024 | ||
Notes | $m | |
Inventories | 9.3 | |
Intangible assets | 16 | 6.6 |
Trade and other receivables | 5.0 | |
Property, plant and equipment | 14 | 3.1 |
Right-of-use assets | 15 | 1.4 |
Assets held for sale | 25.4 | |
Trade and other payables | (6.3) | |
Lease liabilities | (2.3) | |
Liabilities held for sale | (8.6) |
Total | ||
Notes | $m | |
Cash paid | 299.7 | |
Contingent consideration | – | |
Total purchase consideration | 299.7 | |
Less: fair value of net assets acquired | (156.0) | |
Goodwill | 143.7 | |
The fair value of assets and liabilities arising from the acquisition are as follows: | ||
Property, plant and equipment | 14 | 11.2 |
Right-of-use assets | 15 | 2.3 |
Intangible assets – customer relationships | 16 | 17.0 |
Intangible assets – recipes and know-how | 16 | 102.0 |
Intangible assets – brands | 16 | 8.0 |
Inventories | 32(b) | 8.4 |
Trade and other receivables | 32(b) | 14.5 |
Cash and cash equivalents | 1.7 | |
Deferred tax asset | 26 | 7.8 |
Trade and other payables | 32(b) | (8.2) |
Lease liabilities | 32(c) | (2.3) |
Deferred tax liability | 26 | (6.4) |
Fair value of net assets acquired | 156.0 |
2024 | 2023 | |
$m | $m | |
Transactions with joint ventures* | ||
Dividends received** | 5.0 | 32.0 |
Sales of services*** | 51.9 | 12.8 |
Purchases of services | – | 0.1 |
Purchases of goods*** | 23.2 | 1,806.9 |
Loans advanced to Leprino Foods | – | 3.5 |
Repayment of loans advanced by Leprino Foods | – | 71.3 |
Transactions with Tirlán Co-operative Group**** | ||
Dividends received | 0.1 | – |
Dividends paid | 30.1 | 27.4 |
Sales of goods | 0.5 | 0.5 |
Sales of services | 26.8 | 32.4 |
Purchases of services | 0.3 | 0.8 |
Purchases of goods | 64.5 | 61.3 |
Transactions with Leprino Foods* | ||
Sales of services | 2.4 | 2.0 |
2024 | 2023 | |
$m | $m | |
Salaries and other short-term employee benefits | 8.9 | 9.2 |
Post-employment benefits | 0.6 | 0.9 |
Share-based payment expense | 7.9 | 10.3 |
Non-Executive Directors fees | 1.6 | 1.4 |
19.0 | 21.8 |
Registered | |||
Incorporated and operating in | Principal activity | office | |
Ireland | Alanfield Society Limited | Holding society | 1 |
Glanbia AP Designated Activity Company | Financing | 1 | |
Glanbia Cheesip Limited | Research and development | 1 | |
Glanbia Estates Limited | Property and land dealing | 1 | |
Glanbia Finance International Designated Activity | Financing | 1 | |
Company | |||
Glanbia Financial Services Unlimited Company | Financing | 1 | |
Glanbia GNPN Holding Limited | Holding company | 1 | |
Glanbia Holdfin Limited | Holding company | 1 | |
Glanbia Investchip Limited | Holding and managing receivables | 1 | |
Glanbia Investment Holding Limited | Holding company | 1 | |
Glanbia Management Services Limited | Management and general business services | 1 | |
Glanbia Nutritionals Limited | Nutritional ingredients | 1 | |
Glanbia Performance Nutrition Limited | Performance nutrition | 1 | |
Glanbia Property Holding Designated Activity Company | Holding company | 1 | |
Glanbia Property Rentals Designated Activity Company | Property lessor | 1 | |
Glanbia Support Services Limited | Holding company | 1 | |
Glanbia SMP Limited | Holding company | 1 | |
Glassonby Unlimited Company | Financing | 1 | |
Waterford Foods Designated Activity Company | Holding company | 1 | |
United States | APS BioGroup, Inc. | Bioactive solutions | 2 |
of America | Flavor Producers, LLC 4 | Flavours solutions | 2 |
Foodarom USA, Inc. | Flavours solutions | 2 | |
Glanbia Business Services, Inc. | Business services | 2 | |
Glanbia (Delaware), Inc. | Holding company | 2 | |
Glanbia Foods, Inc. | Cheese and nutritional ingredients | 3 | |
Glanbia, Inc. | Holding company | 2 | |
Glanbia Nutritionals (NA), Inc. | Nutritional ingredients | 2 | |
Glanbia Nutritionals, Inc. | Nutritional ingredients | 2 | |
Glanbia Nutritionals Services, LLC | Management services (nutritional ingredients) | 2 | |
Glanbia Performance Nutrition (Manufacturing), Inc. | Performance nutrition | 4 | |
Glanbia Performance Nutrition (NA), Inc. | Performance nutrition | 5 | |
GPN Commercial, LLC | Performance nutrition | 4 | |
GPN SlimFast Commercial, LLC | Weight management solutions | 4 | |
Grass Advantage, LLC | Performance nutrition | 4 | |
KSF Acquisition Corporation | Weight management solutions | 4 | |
La Belle Associates, Inc. | Bioactive solutions | 2 | |
PacMoore Process Technologies, LLC | Nutritional ingredients | 2 | |
Sterling Technology, LLC | Bioactive solutions | 2 |
Registered | |||
Incorporated and operating in | Principal activity | office | |
Britain and Northern Ireland | Glanbia Milk Limited | Management services | 6 |
Glanbia Performance Nutrition (UK) Limited | Performance nutrition | 6 | |
Glanbia Performance Nutrition (UK Sales Division) Limited | Performance nutrition | 6 | |
Glanbia (UK) Limited | Holding company | 6 | |
Australia | Glanbia Performance Nutrition Pty Ltd | Performance nutrition | 7 |
Brazil | Glanbia Marketing de Produtos de Nutrição e | Performance nutrition | 8 |
Performance do Brasil Ltda ¹ | |||
Canada | Foodarom Group Inc. 1 | Flavours solutions | 9 |
Glanbia Nutritionals (Canada) Inc. 1 | Nutritional ingredients | 9 | |
Glanbia Performance Nutrition Canada Inc. 1 | Performance nutrition | 9 | |
China | Glanbia Nutritionals (Suzhou) Co., Ltd. 1 | Nutritional ingredients | 10 |
Glanbia Performance Nutrition Trading (Shanghai) Co., | Performance nutrition | 11 | |
Glanbia (Shanghai) International Trading Co., Ltd. 1 | Nutritional ingredients | 12 | |
Denmark | Nutramino Int. ApS 1 | Performance nutrition | 13 |
France | Glanbia Performance Nutrition France SAS 1 | Performance nutrition | 14 |
Germany | Foodarom Germany GmbH 1 | Flavours solutions | 15 |
Glanbia Nutritionals Deutschland GmbH 1 | Nutritional ingredients | 15 | |
Glanbia Performance Nutrition GmbH 1 | Performance nutrition | 16 | |
LevlUp GmbH ¹ | Performance nutrition | 17 | |
India | Glanbia India Private Limited 2 | Nutritional ingredients | 18 |
Glanbia Performance Nutrition (India) Private Limited 2 | Performance nutrition | 19 | |
Italy | Glanbia Nutritionals Italia Srl | Flavour solutions | 20 |
Japan | Glanbia Japan K.K. 1 | Nutritional ingredients | 21 |
Korea (Republic of) | Glanbia Performance Nutrition Korea, LLC 1 | Performance nutrition | 22 |
Malta | Glanbia Maltfin Limited 1, 3 | Financing | 23 |
Mexico | Glanbia, S.A. de C.V. ¹ | Nutritional ingredients | 24 |
Glanbia Performance Nutrition S.A. de C.V. 1 | Performance nutrition | 25 | |
Netherlands | Body & Fit Sportsnutrition B.V. 1 | Performance nutrition | 26 |
Glanbia Foods B.V. 1 | Holding company | 27 | |
New Zealand | Glanbia Performance Nutrition (New Zealand) Limited 1 | Performance nutrition | 28 |
Philippines | Glanbia Performance Nutrition Philippines, Inc. 1 | Performance nutrition | 29 |
Portugal | Glanbia Nutritionals (Portugal), Sociedade Unipessoal | Performance nutrition | 30 |
Singapore | Glanbia Nutritionals Singapore Pte Limited | Nutritional ingredients | 31 |
Glanbia Performance Nutrition Singapore Pte. Ltd | Performance nutrition | 32 | |
South Africa | Glanbia (Pty) Limited 1 | Nutritional ingredients | 33 |
Sweden | Nutramino AB 1 | Performance nutrition | 34 |
United Arab Emirates | Glanbia Performance Nutrition DMCC 1 | Performance nutrition | 35 |
Uruguay | Glanbia (Uruguay Exports) SA 1 | Nutritional ingredients | 36 |
Registered | |||
Incorporated and operating in | Principal activity | office | |
United States | MWC-Southwest Holdings LLC | Holding company of two cheese and | 2 |
of America | nutritional ingredients companies |